Following the interaction of the T cell receptor (TCR) and the cancer antigen, PD-1 expressed on cytotoxic T cells (CTLs) interacts with PD-L1 expressed on cancer cells, leading to the inhibition of the activation of CTLs and an “immune escape”. The gene discussed is PDCD1; the disease is cancer.